Zepbound 10 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FG8QZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,873
Award facts
- Contract value 100% obligated
- $7,873.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Zepbound 10 mg/0.5 mL pen injectors with a ceiling value of $7,873.22 under firm fixed-price terms. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract was competitively awarded without set-aside designation, with performance to be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and completion scheduled for August 1, 2025.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The broader SPE2DX contract vehicle enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. Zepbound, a diabetes medication, aligns with AmerisourceBergen's established portfolio of specialty pharmaceutical products delivered through the DLA Medical Supply Chain across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FG8QZ?
SPE2DB25FG8QZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 31, 2025.
How much is contract SPE2DB25FG8QZ worth?
The government has obligated $7,873 on SPE2DB25FG8QZ.
Is contract SPE2DB25FG8QZ an order under another contract?
Yes. SPE2DB25FG8QZ is a delivery order under SPE2DB22D1017, an indefinite delivery contract.
Was contract SPE2DB25FG8QZ competed?
The extent of competition for SPE2DB25FG8QZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award